miR‐210‐3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5‐fluorouracil

Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics

(2018) Vittoria Poli et al.   Stem Cells International

MicroRNAs in cancer drug resistance: Basic evidence and clinical applications

(2018) Mehri Ghasabi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

MicroRNAs in the Diagnosis and Treatment of Cancer

(2017) Behzad Mansoori et al.   IMMUNOLOGICAL INVESTIGATIONS

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

(2016) Mary Doherty et al.   Cancers

Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function

(2015) E. Rapizzi et al.   ENDOCRINE-RELATED CANCER

The Role of Hypoxia-Induced miR-210 in Cancer Progression

(2015) Kyvan Dang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits

(2015) Corti Denise et al.   Oncotarget

Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells

(2014) M Mancini et al.   BRITISH JOURNAL OF CANCER

Senescent stroma promotes prostate cancer progression: The role of miR-210

(2014) Maria Letizia Taddei et al.   Molecular Oncology

Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210

(2014) Haopeng Wang et al.   NATURE IMMUNOLOGY

Drug Resistance in Cancer: An Overview

(2014) Genevieve Housman et al.   Cancers

HypoxamiRs and Cancer: From Biology to Targeted Therapy

(2013) Harriet E. Gee et al.   ANTIOXIDANTS & REDOX SIGNALING

Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1  in Advanced Solid Tumors

(2011) S. Kummar et al.   CLINICAL CANCER RESEARCH

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

(2010) M-P Puisségur et al.   CELL DEATH AND DIFFERENTIATION

Dysregulation of microRNAs in cancer: Playing with fire

(2010) Sonia A. Melo et al.   FEBS LETTERS

MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)

(2010) Soken Tsuchiya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Protective Effects of Resveratrol Against Senescence-Associated Changes in Cultured Human Fibroblasts

(2010) Lisa Giovannelli et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Epigenetic modifications as therapeutic targets

(2010) Theresa K Kelly et al.   NATURE BIOTECHNOLOGY

MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress

(2009) M. E. Crosby et al.   CANCER RESEARCH

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2

(2009) Stephen Y. Chan et al.   Cell Metabolism

Role of microRNA in anticancer drug resistance

(2009) Tongsen Zheng et al.   INTERNATIONAL JOURNAL OF CANCER